WISP1 and Macrophage Migration Inhibitory Factor in Respiratory Inflammation: Novel Insights and Therapeutic Potentials for Asthma and COPD

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Sep 28

PMID 39337534

Authors

Maria-Elpida Christopoulou

Alexios J Aletras

Eleni Papakonstantinou

Daiana Stolz

Spyros S Skandalis

Affiliations

Soon will be listed here.

Abstract

Recent advancements highlight the intricate interplay between the extracellular matrix (ECM) and immune responses, notably in respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The ECM, a dynamic structural framework within tissues, orches-trates a plethora of cellular processes, including immune cell behavior and tissue repair mecha-nisms. WNT1-inducible-signaling pathway protein 1 (WISP1), a key ECM regulator, controls immune cell behavior, cytokine production, and tissue repair by modulating integrins, PI3K, Akt, β-catenin, and mTOR signaling pathways. WISP1 also induces macrophage migration inhibitory factor (MIF) expression via Src kinases and epidermal growth factor receptor (EGFR) activation. MIF, through its wide range of activities, enhances inflammation and tissue restructuring. Rec-ognized for its versatile roles in regulating the immune system, MIF interacts with multiple immune components, such as the NLRP3 inflammasome, thereby sustaining inflammatory pro-cesses. The WISP1-MIF axis potentially unveils complex molecular mechanisms governing im-mune responses and inflammation. Understanding the intricate roles of WISP1 and MIF in the pathogenesis of chronic respiratory diseases such as asthma and COPD could lead to the identi-fication of novel targets for therapeutic intervention to alleviate disease severity and enhance patient outcomes.

Citing Articles

Cardiovascular and nonalcoholic fatty liver disease: Sharing common ground through SIRT1 pathways.

Maiese K World J Cardiol. 2024; 16(11):632-643.

PMID: 39600987 PMC: 11586725. DOI: 10.4330/wjc.v16.i11.632.

References

Perez de Llano L, Cosio B, Iglesias A, de Las Cuevas N, Soler-Cataluna J, Luis Izquierdo J . Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach. Int J Chron Obstruct Pulmon Dis. 2018; 13:591-601. PMC: 5813946. DOI: 10.2147/COPD.S153694. View

Roger T, Glauser M, Calandra T . Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. J Endotoxin Res. 2001; 7(6):456-60. View

Liu L, Xu S, Li P, Li L . A novel adipokine WISP1 attenuates lipopolysaccharide-induced cell injury in 3T3-L1 adipocytes by regulating the PI3K/Akt pathway. Obes Res Clin Pract. 2022; 16(2):122-129. DOI: 10.1016/j.orcp.2022.03.001. View

Tank J, Lindner D, Wang X, Stroux A, Gilke L, Gast M . Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts. J Mol Cell Cardiol. 2013; 66:141-56. DOI: 10.1016/j.yjmcc.2013.11.004. View

Skronska-Wasek W, Mutze K, Baarsma H, Bracke K, Alsafadi H, Lehmann M . Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017; 196(2):172-185. DOI: 10.1164/rccm.201605-0904OC. View

Beran D, Zar H, Perrin C, Menezes A, Burney P . Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries. Lancet Respir Med. 2015; 3(2):159-170. DOI: 10.1016/S2213-2600(15)00004-1. View

Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X . Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024; 9(1):130. PMC: 11139930. DOI: 10.1038/s41392-024-01840-1. View

Maiese K, Chong Z, Shang Y, Wang S . Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin Ther Targets. 2012; 16(12):1203-14. PMC: 3500415. DOI: 10.1517/14728222.2012.719499. View

Ndreu L, Sasse S, Karlberg A, Karlsson I . Haptenation of Macrophage Migration Inhibitory Factor: A Potential Biomarker for Contact Hypersensitivity. Front Toxicol. 2022; 4:856614. PMC: 9019732. DOI: 10.3389/ftox.2022.856614. View

10.

Chong D, Rebeyrol C, Jose R, Williams A, Brown J, Scotton C . ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways . Front Immunol. 2021; 12:691957. PMC: 8415445. DOI: 10.3389/fimmu.2021.691957. View

11.

Koopmans T, Crutzen S, Menzen M, Halayko A, Hackett T, Knight D . Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle. Br J Pharmacol. 2016; 173(23):3327-3341. PMC: 5738668. DOI: 10.1111/bph.13620. View

12.

Chen P, Luo Y, Wang W, Wang J, Lai W, Hu S . ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma. Mol Med. 2010; 16(9-10):400-8. PMC: 2935952. DOI: 10.2119/molmed.2009.00128. View

13.

Case N, Ma M, Sen B, Xie Z, Gross T, Rubin J . Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem. 2008; 283(43):29196-205. PMC: 2570859. DOI: 10.1074/jbc.M801907200. View

14.

Wang C, Zhao Y, Su Y, Li R, Lin Y, Zhou X . C-Jun N-terminal kinase (JNK) mediates Wnt5a-induced cell motility dependent or independent of RhoA pathway in human dental papilla cells. PLoS One. 2013; 8(7):e69440. PMC: 3700942. DOI: 10.1371/journal.pone.0069440. View

15.

Florez-Sampedro L, Brandsma C, de Vries M, Timens W, Bults R, Vermeulen C . Genetic regulation of gene expression of MIF family members in lung tissue. Sci Rep. 2020; 10(1):16980. PMC: 7552402. DOI: 10.1038/s41598-020-74121-w. View

16.

Dankers W, Hasnat M, Swann V, Alharbi A, Lee J, Cristofaro M . Necrotic cell death increases the release of macrophage migration inhibitory factor by monocytes/macrophages. Immunol Cell Biol. 2020; 98(9):782-790. DOI: 10.1111/imcb.12376. View

17.

Shi W, Chen F, Cardoso W . Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009; 6(7):558-63. PMC: 3266050. DOI: 10.1513/pats.200905-031RM. View

18.

Kim M, Kim W, Kim D, Byun J, Huy H, Lee S . Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-κB activity. Cell Signal. 2017; 34:110-120. DOI: 10.1016/j.cellsig.2017.03.007. View

19.

Ono M, Inkson C, Kilts T, Young M . WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res. 2010; 26(1):193-208. PMC: 3179320. DOI: 10.1002/jbmr.205. View

20.

Skronska-Wasek W, Gosens R, Konigshoff M, Baarsma H . WNT receptor signalling in lung physiology and pathology. Pharmacol Ther. 2018; 187:150-166. DOI: 10.1016/j.pharmthera.2018.02.009. View